Skip to main content
editorial
. 2018 Jan 31;7(1):20–27. doi: 10.1159/000486487

Fig. 1.

Fig. 1

Treatment strategy using immune checkpoint inhibitors. Future direction: combination therapy. RFA, radiofrequency ablation; TACE, transarterial chemoembolization; HAIC, hepatic arterial infusion chemotherapy; TKIs, tyrosine kinase inhibitors.